Lotus Pharmaceuticals
Taiwan - TaipeiPharmaceutical
Focus: Lotus Pharmaceuticals is a Taiwan-based public generics manufacturer founded in 1966, operating primarily in nephrology and specialty therapeutics with extremely narrow revenue concentration.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About Lotus Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Lotus Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Lotus Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$2K Part D spendingDeclining
Post-LOE
Sole revenue driver (100% of company revenue); post-LOE status and minimal Part D spending indicate mature, commodity market positioning.
Help build intelligence for Lotus Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.